RHI Magnesita (LON:RHIM) Stock Price Up 1% – Here’s What Happened
by Renee Jackson · The Cerbat GemRHI Magnesita (LON:RHIM – Get Free Report)’s share price shot up 1% during trading on Wednesday. The company traded as high as GBX 2,700 and last traded at GBX 2,645. Approximately 1,196,783 shares changed hands during mid-day trading, an increase of 1,050% from the average daily volume of 104,099 shares. The stock had previously closed at GBX 2,620.
Analyst Ratings Changes
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 4,000 target price on shares of RHI Magnesita in a report on Wednesday, September 30th. Three research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 3,453.75.
Get Our Latest Stock Report on RHIM
RHI Magnesita Stock Up 1.0%
The company has a current ratio of 1.48, a quick ratio of 0.93 and a debt-to-equity ratio of 169.57. The stock’s 50-day moving average is GBX 2,836.20 and its 200-day moving average is GBX 2,818.32. The company has a market cap of £1.25 billion, a price-to-earnings ratio of 11.60, a P/E/G ratio of 2.03 and a beta of 1.50.
RHI Magnesita Company Profile
RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with over 20,000 employees in 65 main production sites (including raw material sites), 12 recycling facilities and more than 70 sales offices.
Further Reading
- Five stocks we like better than RHI Magnesita
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors